Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Special Feature
  • Published:

Should we still use vitamin A to prevent bronchopulmonary dysplasia?

Journal of Perinatology volume 36, pages 581–585 (2016)Cite this article

Subjects

Abstract

Bronchopulmonary dysplasia (BPD) is associated with significant short- and long-term morbidity in preterm infants, and it can be prevented in some infants with vitamin A prophylaxis. Vitamin A, once widely used in neonatal intensive care, was scarce for the last few years, but has become available again at a much higher price, leading to dilemmas about its routine use. In this review we discuss experimental, clinical and socioeconomic evidence related to BPD, and provide a framework for clinicians and policy-makers to evaluate the value of vitamin A treatment and make decisions about its use for prevention of BPD.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Maitre NL, Ballard RA, Ellenberg JH, Davis SD, Greenberg JM, Hamvas A et al. Respiratory consequences of prematurity: evolution of a diagnosis and development of a comprehensive approach. J Perinatol 2015; 35 (5): 313–321.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Northway WH Jr . Rosan RC, Porter DY . Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276 (7): 357–368.

    Article  PubMed  Google Scholar 

  3. Jobe AJ . The new BPD: an arrest of lung development. Pediatr Res 1999; 46 (6): 641–643.

    Article  CAS  PubMed  Google Scholar 

  4. Jobe AH, Bancalari E . Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163 (7): 1723–1729.

    Article  CAS  PubMed  Google Scholar 

  5. Vogel ER, Britt RD Jr . Trinidad MC, Faksh A, Martin RJ, MacFarlane PM et al. Perinatal oxygen in the developing lung. Can J Physiol Pharmacol 2015; 93 (2): 119–127.

    Article  CAS  PubMed  Google Scholar 

  6. Couroucli XI, Liang YH, Jiang W, Wang L, Barrios R, Yang P et al. Prenatal administration of the cytochrome P4501A inducer, Beta-naphthoflavone (BNF), attenuates hyperoxic lung injury in newborn mice: implications for bronchopulmonary dysplasia (BPD) in premature infants. Toxicol Appl Pharmacol 2011; 256 (2): 83–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Xia H, Ren X, Bolte CS, Ustiyan V, Zhang Y, Shah TA et al. Foxm1 regulates resolution of hyperoxic lung injury in newborns. Am J Respir Cell Mol Biol 2015; 52 (5): 611–621.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Zhang S, Patel A, Chu C, Jiang W, Wang L, Welty SE et al. Aryl hydrocarbon receptor is necessary to protect fetal human pulmonary microvascular endothelial cells against hyperoxic injury: mechanistic roles of antioxidant enzymes and RelB. Toxicol Appl Pharmacol 2015; 286 (2): 92–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bose CL, Dammann CE, Laughon MM . Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed 2008; 93 (6): F455–F461.

    Article  CAS  PubMed  Google Scholar 

  10. Hair AB, Hawthorne KM, Chetta KE, Abrams SA . Human milk feeding supports adequate growth in infants ⩽1250 grams birth weight. BMC Res Notes 2013; 6: 459.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ambalavanan N, Cotten CM, Page GP, Carlo WA, Murray JC, Bhattacharya S et al. Integrated genomic analyses in bronchopulmonary dysplasia. J Pediatr 2015; 166 (3): 531–537.e513.

    Article  CAS  PubMed  Google Scholar 

  12. Hagood JS . Beyond the genome: epigenetic mechanisms in lung remodeling. Physiology 2014; 29 (3): 177–185.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Cuna A, Halloran B, Faye-Petersen O, Kelly D, Crossman DK, Cui X et al. Alterations in gene expression and DNA methylation during murine and human lung alveolar septation. Am J Respir Cell Mol Biol 2014; 53 (1): 60–73.

    Article  Google Scholar 

  14. Mehta P, Berger J, Bucholz E, Bhandari V . Factors affecting nasal intermittent positive pressure ventilation failure and impact on bronchopulmonary dysplasia in neonates. J Perinatol 2014; 34 (10): 754–760.

    Article  CAS  PubMed  Google Scholar 

  15. Lingappan K, Jiang W, Wang L, Couroucli XI, Moorthy B . Sex-specific differences in hyperoxic lung injury in mice: role of cytochrome P450 (CYP)1 A. Toxicology 2015; 331: 14–23.

    Article  CAS  PubMed  Google Scholar 

  16. Gritz EC, Bhandari V . The human neonatal gut microbiome: a brief review. Front Pediatr 2015; 3: 17.

    PubMed  PubMed Central  Google Scholar 

  17. O'Reilly M, Sozo F, Harding R . Impact of preterm birth and bronchopulmonary dysplasia on the developing lung: long-term consequences for respiratory health. Clin Exp Pharmacol Physiol 2013; 40 (11): 765–773.

    Article  CAS  PubMed  Google Scholar 

  18. McEvoy CT, Jain L, Schmidt B, Abman S, Bancalari E, Aschner JL . Bronchopulmonary dysplasia: NHLBI workshop on the primary prevention of chronic lung diseases. Ann Am Thorac Soc 2014; 11 (Suppl 3): S146–S153.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Baker CD, Abman SH . Impaired pulmonary vascular development in bronchopulmonary dysplasia. Neonatology 2015; 107 (4): 344–351.

    Article  PubMed  Google Scholar 

  20. Blaisdell CJ, Weinmann GG . NHLBI viewpoint: lung health and disease prevention research starting in childhood. Pediatr Pulmonol 2015; 50 (6): 604–606.

    Article  PubMed  Google Scholar 

  21. Bolton CE, Bush A, Hurst JR, Kotecha S, McGarvey L . Lung consequences in adults born prematurely. Thorax 2015; 70 (6): 574–580.

    Article  PubMed  Google Scholar 

  22. Johnson TJ, Patel AL, Jegier BJ, Engstrom JL, Meier PP . Cost of morbidities in very low birth weight infants. J Pediatr 2013; 162 (2): 243–249.e241.

    Article  PubMed  Google Scholar 

  23. Greenough A, Alexander J, Boorman J, Chetcuti PA, Cliff I, Lenney W et al. Respiratory morbidity, healthcare utilisation and cost of care at school age related to home oxygen status. Eur J Pediatr 2011; 170 (8): 969–975.

    Article  PubMed  Google Scholar 

  24. Miller VL, Rice JC, DeVoe M, Fos PJ . An analysis of program and family costs of case managed care for technology-dependent infants with bronchopulmonary dysplasia. J Pediatr Nurs 1998; 13 (4): 244–251.

    Article  CAS  PubMed  Google Scholar 

  25. Landry JS, Croitoru D, Jin Y, Schwartzman K, Benedetti A, Menzies D . Health care utilization by preterm infants with respiratory complications in Quebec. Can Respir J -2012; 19 (4): 255–260.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Sipola-Leppanen M, Vaarasmaki M, Tikanmaki M, Matinolli HM, Miettola S, Hovi P et al. Cardiometabolic risk factors in young adults who were born preterm. Am J Epidemiol 2015; 181 (11): 861–873.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Stocks J, Sonnappa S . Early life influences on the development of chronic obstructive pulmonary disease. Ther Adv Respir Dis 2013; 7 (3): 161–173.

    Article  PubMed  Google Scholar 

  28. Joss-Moore LA, Lane RH, Albertine KH . Epigenetic contributions to the developmental origins of adult lung disease. Biochem Cell Biol 2015; 93 (2): 119–127.

    Article  CAS  PubMed  Google Scholar 

  29. Beam KS, Aliaga S, Ahlfeld SK, Cohen-Wolkowiez M, Smith PB, Laughon MM . A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants. J Perinatol 2014; 34 (9): 705–710.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Viscardi RM . Pharmacological options for BPD prevention: steps for better clinical trial design. J Perinatol 2014; 34 (9): 656–657.

    Article  CAS  PubMed  Google Scholar 

  31. Schmidt B, Roberts R, Millar D, Kirpalani H . Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants. Neonatology 2008; 93 (4): 284–287.

    Article  PubMed  Google Scholar 

  32. Jensen EA, Foglia EE, Schmidt B . Evidence-based pharmacologic therapies for prevention of bronchopulmonary dysplasia: application of the grading of recommendations assessment, development, and evaluation methodology. Clin Perinatol 2015; 42 (4): 755–779.

    Article  PubMed  Google Scholar 

  33. Sommer A, Vyas KS . A global clinical view on vitamin A and carotenoids. Am J Clin Nutr 2012; 96 (5): 1204S–1206S.

    Article  CAS  PubMed  Google Scholar 

  34. Benbrook DM, Chambon P, Rochette-Egly C, Asson-Batres MA . History of retinoic acid receptors. Subcell Biochem 2014; 70: 1–20.

    Article  CAS  PubMed  Google Scholar 

  35. Napoli JL . Physiological insights into all-trans-retinoic acid biosynthesis. Biochim Biophys Acta 2012; 1821 (1): 152–167.

    Article  CAS  PubMed  Google Scholar 

  36. Ghanta S, Leeman KT, Christou H . An update on pharmacologic approaches to bronchopulmonary dysplasia. Semin Perinatol 2013; 37 (2): 115–123.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Maden M, Hind M . Retinoic acid in alveolar development, maintenance and regeneration. Philos Trans R Soc Lond B Biol Sci 2004; 359 (1445): 799–808.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. James ML, Ross AC, Nicola T, Steele C, Ambalavanan N . VARA attenuates hyperoxia-induced impaired alveolar development and lung function in newborn mice. Am J Physiol Lung Cell Mol Physiol 2013; 304 (11): L803–L812.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Gudas LJ . Emerging roles for retinoids in regeneration and differentiation in normal and disease states. Biochim Biophys Acta 2012; 1821 (1): 213–221.

    Article  CAS  PubMed  Google Scholar 

  40. Bourbon J, Boucherat O, Chailley-Heu B, Delacourt C . Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res 2005; 57 (5 Pt 2): 38R–46R.

    Article  PubMed  Google Scholar 

  41. Madanayake TW, Lindquist IE, Devitt NP, Mudge J, Rowland AM . A transcriptomic approach to elucidate the physiological significance of human cytochrome P450 2S1 in bronchial epithelial cells. BMC Genomics 2013; 14: 833.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Dib H, Chafey P, Clary G, Federici C, Le Gall M, Dwyer J et al. Proteomes of umbilical vein and microvascular endothelial cells reflect distinct biological properties and influence immune recognition. Proteomics 2012; 12 (15–16): 2547–2555.

    Article  CAS  PubMed  Google Scholar 

  43. Londhe VA, Maisonet TM, Lopez B, Shin BC, Huynh J, Devaskar SU . Retinoic acid rescues alveolar hypoplasia in the calorie-restricted developing rat lung. Am J Respir Cell Mol Biol 2013; 48 (2): 179–187.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Londhe VA, Nolen TL, Das A, Higgins RD, Tyson JE, Oh W et al. Vitamin A supplementation in extremely low-birth-weight infants: subgroup analysis in small-for-gestational-age infants. Am J Perinatol 2013; 30 (9): 771–780.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Shenai JP, Chytil F, Stahlman MT . Vitamin A status of neonates with bronchopulmonary dysplasia. Pediatr Res 1985; 19 (2): 185–188.

    Article  CAS  PubMed  Google Scholar 

  46. Shenai JP, Rush MG, Stahlman MT, Chytil F . Vitamin A supplementation and bronchopulmonary dysplasia–revisited. J Pediatr 1992; 121 (3): 399–401.

    Article  CAS  PubMed  Google Scholar 

  47. Mactier H, Weaver LT . Vitamin A and preterm infants: what we know, what we don't know, and what we need to know. Arch Dis Child Fetal Neonatal Ed 2005; 90 (2): F103–F108.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Ambalavanan N, Wu TJ, Tyson JE, Kennedy KA, Roane C, Carlo WA . A comparison of three vitamin A dosing regimens in extremely-low-birth-weight infants. J Pediatr 2003; 142 (6): 656–661.

    Article  CAS  PubMed  Google Scholar 

  49. Shenai JP, Kennedy KA, Chytil F, Stahlman MT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr 1987; 111 (2): 269–277.

    Article  CAS  PubMed  Google Scholar 

  50. Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA et al. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1999; 340 (25): 1962–1968.

    Article  CAS  PubMed  Google Scholar 

  51. Ambalavanan N, Tyson JE, Kennedy KA, Hansen NI, Vohr BR, Wright LL et al. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics 2005; 115 (3): e249–e254.

    Article  PubMed  Google Scholar 

  52. Darlow BA, Graham PJ . Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev 2011; (10): CD000501.

  53. Laughon MM . Vitamin A shortage and risk of bronchopulmonary dysplasia. JAMA Pediatr 2014; 168 (11): 995–996.

    Article  PubMed  Google Scholar 

  54. Mactier H . Vitamin A for preterm infants; where are we now? Semin Fetal Neonatal Med 2013.

  55. Meyer S, Gortner L, NeoVita ATI . Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants. Neonatology 2014; 105 (3): 182–188.

    Article  CAS  PubMed  Google Scholar 

  56. Darlow BA, Graham PJ . Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev 2007; (4): CD000501.

  57. Milstone AM, Reich NG, Advani S, Yuan G, Bryant K, Coffin SE et al. Catheter dwell time and CLABSIs in neonates with PICCs: a multicenter cohort study. Pediatrics 2013; 132 (6): e1609–e1615.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Fewtrell MS, Edmonds CJ, Isaacs E, Bishop NJ, Lucas A . Aluminium exposure from parenteral nutrition in preterm infants and later health outcomes during childhood and adolescence. Proc Nutr Soc 2011; 70 (3): 299–304.

    Article  CAS  PubMed  Google Scholar 

  59. Tolia VN, Murthy K, McKinley PS, Bennett MM, Clark RH . The effect of the national shortage of vitamin A on death or chronic lung disease in extremely low-birth-weight infants. JAMA Pediatr 2014; 168 (11): 1039–1044.

    Article  PubMed  Google Scholar 

  60. Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2015; 314 (10): 1039–1051.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Section of Neonatology, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX, USA

    X I Couroucli, J L Placencia, L A Cates & G K Suresh

Authors
  1. X I Couroucli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J L Placencia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L A Cates
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G K Suresh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to X I Couroucli.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Appendix

Appendix

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Couroucli, X., Placencia, J., Cates, L. et al. Should we still use vitamin A to prevent bronchopulmonary dysplasia?. J Perinatol 36, 581–585 (2016). https://doi.org/10.1038/jp.2016.76

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2016.76

This article is cited by

Search

Advanced search

Quick links